baber/WOPTO huggingface dataset:
Patent NZ-582065-A (NZ)
Title: Method and means of reducing loss of hot water vapour from a hot water shrink tunnel
Inventor: CAUDWELL CHRISTOPHER HUGH
IPC: B65B53/04
Filed: 2008-09-02
Abstract: A hot water shrink tunnel (10) is disclosed which includes a heat chamber without a flue or vent. The heat chamber has an inlet opening (12) and an outlet opening (13) each closed by a closing device (21) and a means for conveying product through the heat chamber. A duct (17, 18) is mounted adjacent each opening to capture hot water vapour which issues from the heat chamber when product passes through the closing device (21). A method of operating such a shrink tunnel (10) is also disclosed.
Patent NZ-582526-A (NZ)
Title: Methods of inhibiting ethylene responses in plants using cyclopropene amine compounds
Inventor: SISLER EDWARD C
IPC: A01N3/02
Filed: 2008-06-13
Abstract: Disclosed is a method of inhibiting an ethylene response in a plant (particularly a cut flower), comprising applying to the plant an effective ethylene response-inhibiting amount of at least one cyclopropene amine compound having the structure shown herein or a salt or composition thereof, wherein said salt of the compound may be selected from the group consisting of phosphate, acetate, formate, carbonate, hydrobromide, hydrochloride, sulfate, bisulfate, nitrate, acetate, trifluoroacetate, oxalate, valerate, oleate, palmitate, stearate, laurate, borate, benzoate, lactate, tosylate, citrate, maleate, fumarate, succinate, tartrate, naphthylate, mesylate, glucoheptonate, lactiobionate and laurylsulfonate salts, and wherein said ethylene response may be one or more of ripening or senescence of flowers, fruits, and vegetables; abscission of foliage, flowers, and fruit; the shortening of life of ornamental plants, cut flowers, shrubbery, seeds, or dormant seedlings; inhibition of growth; stimulation of growth; auxin activity; inhibition of terminal growth; control of apical dominance; increase in branching; increase in tillering; changing the morphology of plants; modifying the susceptibility to plant pathogens including fungi; changing bio-chemical compositions; inducing pest resistance; abortion or inhibition of flowering or seed development; lodging effects; stimulation of seed germination; breaking of dormancy; hormone effects; and epinasty effects.
Patent NZ-582647-A (NZ)
Title: Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants
Inventor: PRUSS REBECCA
IPC: A23L33/00
Filed: 2008-07-24
Abstract: 582647 Disclosed herein is the use of at least one derivative of 3,5-seco-4-norcholestane oxime corresponding to formula I, wherein the variables are defined in the specification for the manufacture of an antioxidant composition for the treatment or prevention of cosmetic conditions caused by damage from free radicals. Specifically wherein the derivative of 3,5-seco-4-norcholestane oxime is chosen from: 3,5-seco-4-norcholestan-5-one oxime-3-ol, 3,5-seco-4-norcholestan-5-one oxime-3 -methyl alcohol, or 3,5-seco-4-norcholestan-5-one oxime-3 -dimethyl alcohol.
Patent NZ-589340-A (NZ)
Title: Current sensor detecting change in light polarisation in a light guide near a power line
Inventor: SORENSE FREDDY
IPC: G01R15/24
Filed: 2009-05-29
Abstract: A Faraday optical current sensor arrangement (10) for measuring the current through a power line (18). The arrangement (10) is comprised of a Faraday optical current sensor (38) having an elongated and substantially cylindrical shape defining a first end and a second end opposite the first end. The Faraday optical current sensor (38) has a first optical conduit (48) extending from the first end and a second optical conduit (48) extending from the second end. A hollow housing (12, 14) is also provided enveloping the Faraday optical current sensor (38) and retaining the Faraday optical current sensor (38) in a fixed position relative to and within the hollow housing (12, 14). The hollow housing (12, 14) defines an internal channel for accommodating the Faraday optical current sensor (38) and the first and second optical conduits (48). The hollow housing (12, 14) has a single opening (15) providing access to the internal channel, wherein the single opening (15) provides the only means of access between the interior and exterior of the hollow housing (12, 14). The hollow housing (12, 14) including a holder (16) for fixedly arranging the power line (18) and the hollow housing (12, 14) relative to one another in a juxtaposed position and positioning the Faraday optical current sensor (38) in a suitable measuring position relative to the power line (18).
Patent NZ-589585-A (NZ)
Title: Stackable twin separable egg packaging unit with hinged lid
Inventor: DIJKSTRA WIJBE
IPC: B65D85/32
Filed: 2009-06-03
Abstract: A pair set of mutually connected packaging units or cartons for eggs or similar fragile articles such as kiwifruit, made of moulded paper pulp and each packaging unit comprising: a bottom part comprising compartments that match the contours of the articles contained within said unit; a cover lid comprising a top surface and substantially planar or flat front- and rear surfaces and side end surfaces, said cover part being a rectangular shape with rounded comers hinged to the bottom part, with bridges containing a compressed higher density band of 3-10 mm width and with a thickness of 30-70% compared to the rest of the bridge, connecting the pair of packaging units either on the lid or the bottom part or both parts. The packaging unit is made in a pre-mould from pulp and squeezed to form the shape. A raised or elevated ridge or region extends to a height of 0.3-0.6 mm above the mould wall to form the compressed bridge.
Patent NZ-590495-A (NZ)
Title: Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
Inventor: HIMMELSBACH FRANK
IPC: A61K31/5355
Filed: 2009-07-23
Abstract: Disclosed are substituted dihydropyridin-phenyl-3-oxazinan-2-ones of formula (Io1) pharmaceutically acceptable salt, enantiomer or diastereomer thereof which are inhibitors of 11beta-hydroxysteroid dehydrogenase 1, wherein the variables are as defined in the specification. These compounds are suitable for the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell, and are useful in the therapeutic treatment of diseases (such as diabetes mellitus) associated with the modulation or inhibition of 11beta-HSD1 in mammals.
Patent NZ-593086-A (NZ)
Title: Isolated peptide binding to human leukocyte antigen (HLA) and having cytotoxic T lymphocyte (CTL) inducibility
Inventor: TSUNODA TAKUYA
IPC: A61K39/00
Filed: 2009-12-03
Abstract: An isolated peptide of less than about 15 amino acids, capable of binding to an HLA antigen and having cytotoxic T lymphocyte (CTL) inducibility, which comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 1, 3,4, 16, and 17.
Patent NZ-596000-A (NZ)
Title: Carboxamide compounds and their use as calpain inhibitors
Inventor: MACK HELMUT
IPC: A61K31/4412
Filed: 2010-05-06
Abstract: 596000 Disclosed herein are carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof.
Patent NZ-597671-A (NZ)
Title: Closure for an easy opening container and a container provided with such closure
Inventor: DELTOUR BERNARD
IPC: B65D17/50
Filed: 2011-03-15
Abstract: Disclosed is a closure (1) for an easy opening container. The closure comprises a ring (2) having a flat support (13) connected via a ring wall (14) to an outer curl (12), located at a lower level than the ring, and a foil (3) adhered to the support. The foil is provided with a tab (4) comprising a folded part connected via an intermediate part (8) to a free end tab part (9). The tab is folded onto the foil. The foil further comprises a central concave section (5) and at least a flat section (6) beneath the intermediate tab part folded over an onto the flat foil section. The intermediate part of the tab is adhered to the foil such that after pressure builds up in the container, the tab remains attached to the foil within the confinement of the closure.
Patent NZ-616353-A (NZ)
Title: Method of treating vision disorders
Inventor: SMITH CRAIG
IPC: C07K16/22
Filed: 2012-05-04
Abstract: A method for monitoring a patient’s response to treatment of an eye disorder where the patient has been treated with ranibizumab, bevacizumab or aflibercept is disclosed. The patient’s response to treatment is monitored remotely by the physician using a remote device that is able to carry out a sight test and supply the results to the physician and the results indicate alteration to the patient’s treatment regime such that visual function is maintained above a threshold level.
Patent NZ-617674-A (NZ)
Title: Method for operating a wind energy plant in icing conditions
Inventor: JEPSEN TORSTEN
IPC: F03D7/02
Filed: 2012-05-24
Abstract: The present invention relates to a method for operating a wind energy plant (1), comprising a nacelle (2) having an electric generator for generating electric current, and an aerodynamic rotor (3) having one or more rotor blades (4), the rotor being coupled to the generator. The method comprises the steps of operating the wind energy plant (1) if ice build-up on the rotor blades (4) can be safely ruled out, and of stopping the wind energy plant (1), if ice build-up on the rotor blades (4) is detected, and time-delayed stopping and/or preventing a restart of the wind energy plant (1), if an ice build-up was not detected but is to be expected, and/or time-delayed restart of the wind energy plant (1) if a stop condition, which led to a shut-down of the wind energy plant (1), no longer applies, and an ice build-up was not detected, and an ice build-up or the formation of an ice build-up is not to be expected.
Patent NZ-618004-A (NZ)
Title: Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy} phenyl)-n’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Inventor: GALLAGHER WILLIAM P
IPC: C07D215/22
Filed: 2010-01-15
Abstract: Disclosed is a process for preparing cabozantinib (N-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy} phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide / N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide / BMS-907351 / XL-184), comprising the steps of: (a) preparing 4-chloro-6,7-dimethoxy-quinoline by reacting 6,7-dimethoxy-1H-quinolin-4-one / 6,7-dimethoxy-quinoline-4–ol with phosphoryl chloride (POCl3) in acetonitrile; (b) preparing 6,7–dimethoxy-4-(4-nitro-phenoxy)-quinoline by reacting 4-chloro-6,7-dimethoxy-quinoline with 4-nitrophenol in the presence of 2,6-lutidine; (c) preparing 6,7–dimethoxy-4-(4-amino-phenoxy)-quinoline / 4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylamine by reducing 6,7–dimethoxy-4-(4-nitro-phenoxy)-quinoline in the presence of formic acid, potassium formate, and Palladium on carbon in tetrahydrofuran; and (d) preparing cabozantinib by reacting 4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylamine with 1-(4-fluoro-phenylcarbamoyl)-cyclopropanecarbonyl chloride in the presence of potassium carbonate, water, and tetrahydrofuran. Also disclosed are processes for the preparation of crystalline and amorphous forms of cabozantinib malate.
Patent NZ-622915-A (NZ)
Title: Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine
Inventor: ALEXANDRE LE FLOHIC
IPC: C07D223/16
Filed: 2014-03-25
Abstract: Disclosed is a process for the synthesis of a compound of formula I (a 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one) from the reduction of a 7,8-dimethoxy-benzazepine-2,4(3H,5H)-dione of formula VII. Also disclosed is the use of this process in the synthesis of ivabradine. Further disclosed are two intermediates from the synthesis, the compound of formula VIII 3-{ 3-[{ [(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl} (methyl)amino]-propyl} -7,8-dimethoxy-1H-3-benzazepine-2,4(3H,5H)-dione and also the compound of formula XIV { 2-[2-({ 3-[{ [(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl} (methyl)-amino]propyl} amino)-2-oxoethyl]-4,5-dimethoxyphenyl} acetic acid.
Patent NZ-707833-A (NZ)
Title: Polyvalent pollution removal composition and use thereof
Inventor: BLOMET JOëL
IPC: C09K3/32
Filed: 2013-11-28
Abstract: The invention relates to a pollution removal composition comprising: (a) at least one silica gel, and (b) at least one wood derived absorbing agent, wherein said silica gel has a particle size from 60 to 500 µm, and a mass density from 150 to 400 kg/m3, said wood derived absorbing agent being selected from wood sawdust, wood chips, wood powder, chopped straw, ground corn, cellulose, hemicellulose, lignin, and mixtures thereof, and the mass ratio between the silica gel and the wood derived absorbent being from 95:5 to 60:40.
Patent NZ-708445-A (NZ)
Title: Therapeutic cd47 antibodies
Inventor: FRAZIER WILLIAM
IPC: C07K16/46
Filed: 2013-12-12
Abstract: Provided are monoclonal antibodies and antigen-binding fragments thereof that bind to, and inhibit the activity of, CD47, as well as monoclonal antibodies and antigen binding fragments thereof that compete with the former for binding to CD47. Also provided are combinations of any of the foregoing. Such antibody compounds are variously effective in 1) treating tissue ischemia and ischemia-reperfusion injury (IRI) in the setting of organ preservation and transplantation, pulmonary hypertension, sickle cell disease, myocardial infarction, stroke, and other instances of surgery and/or trauma in which IRI is a component of pathogenesis; 2) in treating autoimmune and inflammatory diseases; and 3) as anti-cancer agents that are toxic to susceptible cancer cells, promoting (increasing) their phagocytic uptake and clearance, and/or directly killing such cells.
Patent NZ-708511-A (NZ)
Title: Methods for controlling blood pressure and reducing dyspnea in heart failure
Inventor: SPINDLER EDWARD
IPC: A61K31/4422
Filed: 2013-10-26
Abstract: Methods for controlling, maintaining, or reducing blood pressure, and/or for treating, preventing, or alleviating symptoms such as dyspnea, in a patient suffering from or susceptible to acute heart failure. The methods involve the administration of an effective amount of a pharmaceutical composition comprising a short acting dihydropyridine compound such as clevidipine. The pharmaceutical composition may be administered at an initial dose, and if blood pressure is not controlled or maintained within a target blood pressure range or reduced to within a target blood pressure range, the initial dose may be titrated to achieve a blood pressure within the target blood pressure range. The patient may have a systolic blood pressure of about 120 mmHg or above.
Patent NZ-716582-A (NZ)
Title: Endoscopy device
Inventor: POULSEN SYLWIA
IPC: A61M16/04
Filed: 2014-08-15
Abstract: An endoscopy device (1) for facilitating use of an endoscope, comprising at least one airway tube (2) having a proximal end (2a) and a distal end (2b) and a mask (3) carried at the distal end (2b) of the airway tube (2). The mask (3) has a distal end (4), a proximal end (5) and a peripheral formation (6) capable of conforming to, and fitting within, the actual and potential space behind the larynx of the patient to form a seal around the circumference of the laryngeal inlet. The peripheral formation (6) surrounds a hollow interior space or lumen of the mask (3) and the at least one airway tube (2) opening into the lumen of the mask (3), and establishes separation between a laryngeal chamber region (3a) and a pharyngeal region (3b). The device (1) further comprises a conduit (8) adapted for passage of an endoscope into the oesophagus of a patient when the mask (3) is in place. The airway tube (2) comprises a connector (12) at its proximal end (2a) , the connector (12) having one or more strap mount comprising a mount bar to which a strap can be removably fixed for securing the device (1) to a patient. The conduit (8) includes an internal sleeve at its proximal end and the sleeve is integrally formed with the connector (12). Compared to prior art devices, the device (1) may provide improved stability in use and assist in attachment of the device (1) to a patient.
Patent NZ-722076-A (NZ)
Title: Chimeric antigen receptor containing a toll-like receptor intracellular domain
Inventor: Yunxin Lai
IPC: C07K19/00
Filed: 2015-08-07
Abstract: The present invention relates to a chimeric antigen receptor, comprising an extracellular domain capable of binding to an antigen, a transmembrane domain and an intracellular domain; a nucleic acid encoding the same and a cell expressing the same, and their use in manufacturing drugs for treating tumors. The chimeric antigen receptor of the present invention is characterized by its intracellular domain including at least Toll-like receptor 1 being encoded by the nucleotide sequence of SEQ ID NO: 11 and/or Toll-like receptor 2 intracellular domain being encoded by the nucleotide sequence of SED ID NO: 12.
Patent NZ-733561-A (NZ)
Title: A method of fishing with unmanned aerial vehicle
Inventor: TAO GAN
IPC: G01S15/00
Filed: 2017-07-07
Abstract: The present disclosure discloses a method of using an unmanned aerial vehicle (UAV) comprising a housing, a processor, a positioning unit, a sonar unit, a launching unit and a fishhook unit in fishing. The method comprises manipulating the UAV to fly to a designated destination determined by the processor according to one of a received wireless communication and a preset program, adjusting the sonar unit to a predetermined height by the positioning unit, determining a coordinate corresponding to a signal detected by the sonar unit as a fishing region when the signal is consistent with a predetermined value, launching bait to the fishing region by the launching unit, releasing a fishhook from the fishhook unit to the fishing region, and manipulating the UAV to hover or return by the processor according to one of a received wireless communication and a preset program.
Patent NZ-761547-A (NZ)
Title: Bispecific antibody
Inventor: SHIBAYAMA SHIRO
IPC: C07K16/46
Filed: 2019-02-08
Abstract: The present invention addresses the problem of providing a novel drug for the prevention of autoimmune diseases, the suppression of the progression of the symptoms of autoimmune diseases, the suppression of the recurrence of autoimmune diseases, or the treatment of autoimmune diseases. As a result of diligent investigation, the inventors of the present invention have focused on PD-1/CD3 bispecific antibodies as substances that can solve the abovementioned problem and have confirmed that said bispecific antibodies make it possible to achieve pharmaceuticals that reduce the occurrence of the adverse effects known as infusion-related reaction and cytokine release syndrome. In addition, the inventors have confirmed that said bispecific antibodies allow for interaction between PD-1 and its ligand PD-L1 and have discovered that said feature contributes to enhanced and sustained activity.
Patent NZ-782045-A (NZ)
Title: Nasal assembly
Inventor: JUDSON DANIEL ROBERT
IPC: A62B18/00
Filed: 2006-10-13
Abstract: An oro-nasal mask assembly for delivering pressurized breathable air to a patient, comprising: a frame having a main body with a bore to receive the pressurized air, the frame having an upper support member and a longitudinal axis dividing the bore and extending along the upper support member; a forehead support supported by the upper support member; an elbow in communication with the bore; and a cushion configured to seal around the nose and mouth of the patient in use, the cushion being coupled with the main body of the frame, wherein the frame includes a vent arrangement positioned along the longitudinal axis between the bore and the upper support member, the vent arrangement comprising a three column pattern including a center column and a pair of outside columns, the center column being aligned with the longitudinal axis and each of the outside columns being parallel to but offset from the longitudinal axis, wherein the center column includes 10-20 holes and each said outside column includes 8-15 holes.
Patent PT-102201-A (PT)
Title: Protective closure against fire formed with a door leaf or large gate leaf
IPC: E06B5/16
Filed: 1998-09-04
Abstract: A protective closure 1 against fire, formed with a door leaf or a large gate leaf 5, is composed of a box, formed by two cover sheets 6, 7 bent at an angle, provided in its inside with at least one reinforcement element. In order to be able to produce such a door or large gate leaf 5, with a reduced weight and with high rigidity, it is proposed that the reinforcement element consist of a plurality of strips of paper or cardboard 12, the width of which is identical to the inner thickness 11 of the box and that are glued, at their sides, to the width between them, in specific sections, in order to form a unit, so that they can be glued, it being possible to separate one from another, in order to form a network structure in the form of a honeycomb 13 and, in this state, glued to the cover sheets 6, 7 at the top sides of the strips 12. <IMAGE>
Patent PT-117882-A (PT)
Title: Substrato celulósico para identificação ótica de compostos nitroaromáticos explosivos e seu método de produção
Inventor: ANTONIO PAULO MENDES DE SOUSA
IPC: G01N21/64
Filed: 2022-03-28
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A UM SUBSTRATO CELULÓSICO PARA IDENTIFICAÇÃO ÓTICA DE COMPOSTOS NITROAROMÁTICOS EXPLOSIVOS QUE COMPREENDE POLÍMEROS QUE APRESENTAM RESPOSTA ÓPTICA VISÍVEL A OLHO NU OU RELACIONADA A FENÓMENOS DE FLUORESCÊNCIA, EM RELAÇÃO A COMPOSTOS NITROAROMÁTICOS, TAIS COMO 2,4-DINITROTOLUENO, TRINITROTOLUENO OU ISÓMEROS DE DINITROBENZENO, EM FASE GASOSA. ESTES GASES SÃO EMITIDOS POR MINAS ANTIPESSOAL BASEADAS EM TRINITROTOLUENO. AS SOLUÇÕES OU SUSPENSÕES DE REVESTIMENTO CONSIDERADAS NESTA INVENÇÃO CONTÊM PELO MENOS UM POLÍMERO QUE APRESENTA RESPOSTA ÓPTICA POR MUDANÇA DE COR OU SUPRESSÃO DE LUMINESCÊNCIA, EM RELAÇÃO A PELO MENOS UM DOS COMPOSTOS NITROAROMÁTICOS MENCIONADOS. OS POLÍMEROS DESCRITOS NESTA INVENÇÃO TÊM BOA AFINIDADE COM A SUPERFÍCIE DO PAPEL, GARANTIDA PELOS GRUPOS AMÓNIO QUATERNÁRIOS OU AMINO TERCIÁRIOS. A ESTABILIZAÇÃO DA SOLUÇÃO OU SUSPENSÃO DE REVESTIMENTO É ALCANÇADA POR MEIO DE SURFACTANTES ANIÓNICOS OU POR MEIO DO USO DE ETANOL COMO CO-SOLVENTE. UM ASPETO ADICIONAL DA PRESENTE INVENÇÃO DIZ RESPEITO AO MÉTODO DE PRODUÇÃO DOS SUBSTRATOS CELULÓSICOS DESCRITOS.
Patent RU-94017452-A (RU)
Inventor: STOPSKIJ V S
IPC: C11B3/04
Filed: 1994-05-13
Abstract: FIELD: fat and oil industry. SUBSTANCE: hydrated oil is treated with aminoacetic acid or its sodium salt (at the mole ratio 1.2-3.0 with regard to sulfur compounds) being before or in the process of neutralization. EFFECT: decreased reagent consumption (ammonia or amine derivative), decreased sewage volume.